(Reuters) - Former Perrigo Co Plc (PRGO.N) head Joseph Papa was named Chief Executive ... said Wells Fargo analyst David Maris, who downgraded the stock to market perform. Papa does not have significant experience in branded …
Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded …
Perrigo Co Plc (NASDAQ:PRGO) crossed over its 10-day moving average of $77.84 on a volume of 258K shares. This may provide short-term investors a chance for a long position, as such a crossover often suggests higher prices in the near …
The US drug development company has a market cap of $1.43 billion. The Tel Aviv Stock Exchange (TASE) has approved the dual-listing of US drug development company MannKind Corporation (NASDAQ: MNKD). Based in …
Next 5 years (per annum) 5.28% N/A N/A 0.10 Past 5 years (per annum) 14.89% N/A N/A N/A
Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded …
Here are the sectors that made the biggest moves today: Perrigo’s (PRGO) gain led pharmaceuticals higher. Recreational products gained, including Mattel (MAT). DaVita (DVA) boosted medical and nursing ...
Drugmaker Mylan lost its bid Friday to take over Ireland-based Perrigo after it failed to get enough support from shareholders in its hostile $35 billion bid. Mylan had spent seven months in pursuit of Perrigo, which makes …